Global Metagenomic Sequencing Market: Key Segments, Growth Trajectories, and More” – ResearchAndMarkets.com
Global Metagenomic Sequencing Market: Key Segments, Growth Trajectories, and More” – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Metagenomic Sequencing – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The report presents a comprehensive analysis of the global metagenomic sequencing market, focusing on geographic regions including the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
It provides insights into the recent past, current, and future trends for metagenomic sequencing, including annual sales data in US$ Thousand for the years 2022 through 2030 and percentage CAGR.
The analysis covers various aspects such as metagenomic sequencing, reagents & consumables, instruments, services, analysis & data interpretation solutions, clinical diagnostics, soil microbiome, industrial applications, other applications, drug discovery, shotgun sequencing, 16S rRNA, metatranscriptomics, and whole-genome sequencing & de novo assembly.
These insights aid in understanding the evolving market landscape and its potential growth trajectories, facilitating informed decisions for businesses and stakeholders.
Global Metagenomic Sequencing Market to Reach $9.6 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Metagenomic Sequencing estimated at US$2.8 Billion in the year 2022, is projected to reach a revised size of US$9.6 Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2022-2030.
Reagents & Consumables, one of the segments analyzed in the report, is projected to record 19.1% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 16.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $752.3 Million, While China is Forecast to Grow at 24% CAGR
The Metagenomic Sequencing market in the U.S. is estimated at US$752.3 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 24% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 14% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.5% CAGR.
What’s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its ‘bumpy’ reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
A selection of companies mentioned in this report includes
- BGI Group
- DNAStar, Inc.
- Eurofins Scientific
- GENEWIZ
- Illumina, Inc.
- IntegraGen SA
- Macrogen, Inc.
- Microsynth AG
- Novogene Corporation
- NuGEN Technologies, Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research Corporation
For more information about this report visit https://www.researchandmarkets.com/r/st6yqp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900